SCHEMBL6559984

SCHEMBL6559984

O=C1CCCCN(S(=O)(=O)c2ccccc2F)C1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
TSHR P16473 2/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
ALDH1A1 P00352 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 1/20 0.45
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA4 P43681 1/20 0.45
PGR P06401 1/20 0.44
EPHX2 P34913 1/20 0.44
MEN1 O00255 1/20 0.44
PKM P14618 2/20 0.44
PKLR P30613 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14489596 0.85 TSHR (0.71) KMT2AL3MBTL1TSHRCYP3A4CYP2C9
SCHEMBL20145597 0.84 TSHR (0.75) KMT2AL3MBTL1TSHRCYP3A4CYP2C9
SCHEMBL19348478 0.79 KMT2A (0.67) KMT2AL3MBTL1TSHRCYP3A4CYP2C9
SCHEMBL10884111 0.76 KMT2A (0.51) KMT2AL3MBTL1TSHRCYP3A4CYP2C9
SCHEMBL13692619 0.75 KMT2A (0.54) KMT2AL3MBTL1TSHRCYP3A4CYP2C9
SCHEMBL5455308 0.74 KMT2A (0.53) KMT2AL3MBTL1TSHRCYP3A4CYP2C9
SCHEMBL4001721 0.74 KMT2A (0.52) KMT2AL3MBTL1TSHRCYP3A4CYP2C9
SCHEMBL6559920 0.74 PKM (0.44) TSHRCYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL3245089 0.73 CYP3A4 (0.60) KMT2AL3MBTL1TSHRCYP3A4CYP2C9
SCHEMBL7650437 0.72 KMT2A (0.58) KMT2AL3MBTL1TSHRCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP claimed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO claimed